Simplified Report on Change of Equity (Jiaxing Huixin)

Anhui Hongyu Wuzhou Medical Instrument Co., Ltd.

Simplified Report on Change of Equity

Company Name: Anhui Hongyu Wuzhou Medical Instrument Co., Ltd.

Stock Exchange: Shenzhen Stock Exchange

Stock Abbreviation: Wuzhou Medical

Stock Code: 301234

Information Disclosure Obligor: Jiaxing Huixin Enterprise Management Partnership (Limited Partnership)

Domicile: Room 217-49, Building 1, Fund Town, No. 1856 Nanjiang Road, Dongzha Street, Nanhu District, Jiaxing City, Zhejiang Province

Correspondence Address: Room 1713, Block A, Lenovo Houhai Center, No. 3288 Houhaibin Road, Nanshan District, Shenzhen

Nature of Equity Change: Increase in shares (agreement transfer)

Date of Signing: July 2026

Declaration of Information Disclosure Obligor

1. This report is prepared by the information disclosure obligor in accordance with the Securities Law of the People's Republic of China, the Administrative Measures for the Takeover of Listed Companies, the Standards for the Contents and Formats of Information Disclosure by Companies Offering Securities to the Public No. 15—Report on Change of Equity, and other relevant laws, regulations, and normative documents.

2. The signing of this report by the information disclosure obligor has obtained the necessary authorization and approval, and its performance does not violate or conflict with any clauses in the articles of association or internal rules of the information disclosure obligor.

3. In accordance with the provisions of the aforementioned laws and regulations, this report has fully disclosed the changes in the equity held by the information disclosure obligor in Anhui Hongyu Wuzhou Medical Instrument Co., Ltd. (hereinafter referred to as "Wuzhou Medical" or the "Listed Company"). As of the date of signing this report, except for the shareholding information disclosed in this report, the information disclosure obligor has not increased or decreased its equity in the listed company through any other means.

4. This equity change is conducted based on the information stated in this report. The information disclosure obligor has not entrusted or authorized any other person to provide information not listed in this report or to make any interpretation or explanation of this report.

5. The information disclosure obligor promises that this report does not contain any false records, misleading statements, or major omissions, and assumes individual and joint legal liability for its authenticity, accuracy, and completeness.

6. This equity change is still subject to the compliance confirmation of the Shenzhen Stock Exchange and the transfer registration procedures at the Shenzhen Branch of China Securities Depository and Clearing Corporation Limited. There is uncertainty regarding whether this equity change can be successfully implemented and when it will be completed. Investors are advised to invest rationally and pay attention to investment risks.

Table of Contents

1. Declaration of Information Disclosure Obligor

2. Table of Contents

3. Section I Definitions

4. Section II Introduction to Information Disclosure Obligor

5. Section III Purpose of Equity Change

6. Section IV Method of Equity Change

7. Section V Transactions of Listed Shares in the Previous Six Months

8. Section VI Other Major Matters

9. Section VII Documents Available for Inspection

10. Appendix

Section I Definitions

In this report, unless otherwise stated, the following abbreviations have the following specific meanings: